Page 22 - P4403.14_V87_YOUROTC_Book DECEMBER_2023 NI PRINT Final 23

22 HEALTHCARE

Not all topical diclofenac products are the same.
Formulation Matters. 1

The only clinically proven

2.32% diclofenac gel to
demonstrate deep tissue

penetration into joints 2

Save

Up Off
To9%
Trade

Double concentration* –

now indicated for

relief of osteoarthritis pain Diclofenac diethylammonium

Voltarol Max Strength The permeation Effective delivery
Pain Relief 2.32% Gel enhancer delivers of diclofenac
strikes at the site of up to 3x greater skin through the skin
pain and inflammation penetration*
3

Up to 12 hours long lasting pain relief for sprains,
strains, back pain, joint pain and now osteoarthritis

Learn more about the formulation of Voltarol Gel

*vs 1% diclofenac gel
References: 1. Derry S et al. Cochrane Database Syst Rev 2015; 6: CD007402. 2. Seefried et al. Ther Adv Musculoskel Dis (2020) Vol 12: 1-13. 3. Quartatone & Hasler-Nguyen.
2014. Haleon Data on File.
Product Information: Voltarol Max Strength Pain Relief 2.32% Gel (diclofenac diethylammonium). Indications: Local symptomatic relief of pain and inflammation in trauma
of the tendons, ligaments, muscles and joints e.g. due to sprains, strains and bruises, and localised forms of soft tissue rheumatism. Relief of pain of non-serious arthritic
conditions. Legal category: P. Licence holder: Haleon UK Trading Limited, The Heights, Weybridge, KT13 0NY, U.K..
Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at:
https://www.medicines.org.uk/emc/product/8775/smpc
Trade marks are owned by or licensed to the Haleon group of companies. PM-GB-VOLT-23-00026.

05/05/2023 15:00
SM4343 2023_UK_Voltarol - Accelaration Print Insert 4_PRINT_FOR_PRESS.indd 1 05/05/2023 15:00
SM4343 2023_UK_Voltarol - Accelaration Print Insert 4_PRINT_FOR_PRESS.indd 1

13/11/2023 15:06:27
P4403.14_V87_YOUROTC_Book DECEMBER_2023 NI.indd 22
P4403.14_V87_YOUROTC_Book DECEMBER_2023 NI.indd 22 13/11/2023 15:06:27